United States· US:0069-2465_22c6b04d-858c-4a16-9593-5643aabb0da9
Abrysvo
A medicinal product containing recombinant stabilized rsv a prefusion f antigen; recombinant stabilized rsv b prefusion f antigen, registered in United States by Pfizer Laboratories Div Pfizer Inc.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- RECOMBINANT STABILIZED RSV A PREFUSION F ANTIGEN; RECOMBINANT STABILIZED RSV B PREFUSION F ANTIGEN
- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- July 19, 2026
Packs & prices · 4
- ndc1100692465011 VIAL in 1 CARTON (0069-2465-01) / .5 mL in 1 VIAL (0069-2465-19)
- ndc11006924651010 VIAL in 1 CARTON (0069-2465-10) / .5 mL in 1 VIAL (0069-2465-19)
- ndc110069-2465-01
- ndc110069-2465-10
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9cbe3922-a31d-4c23-8fd0-c3068724c72e GET /v1/drugs/9cbe3922-a31d-4c23-8fd0-c3068724c72e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAMUSCULAR",
"source": "ndc",
"strength": ".06; .06",
"substance": "RECOMBINANT STABILIZED RSV A PREFUSION F ANTIGEN; RECOMBINANT STABILIZED RSV B PREFUSION F ANTIGEN",
"productndc": "0069-2465",
"dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/.5mL; mg/.5mL",
"application_number": "BLA125769",
"marketing_category": "BLA"
}See everything about recombinant stabilized rsv a prefusion f antigen; recombinant stabilized rsv b prefusion f antigen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.